Form 8-K - Current report:
SEC Accession No. 0001144204-19-009816
Filing Date
2019-02-25
Accepted
2019-02-25 14:29:51
Documents
1
Period of Report
2019-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv514415_8k.htm 8-K 18323
  Complete submission text file 0001144204-19-009816.txt   19537
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 19628992
SIC: 2836 Biological Products, (No Diagnostic Substances)